Table 1 Clinical characteristics of the participants.

From: Effects of inpatient treatment of adolescents with anorexia nervosa are associated with body representation: a monocentric pilot study

 

AN group (T1) n = 12

AN group (T2) n = 12

HC group n = 14

P

Post-hoc analysis

Age (month)

160.2 (16.6)

162.8 (17.7)

172.1 (5.1)

0.080

 

Illness duration (month)

7.0 (4.2)

    

Height (cm)

153.8 (6.9)

154.0 (7.2)

157.4 (5.5)

0.284

 

Weight (kg)

29.9 (5.4)

37.7 (5.2)

49.2 (5.4)

 < 0.001

T1 < T2, T1 < HC, T2 < HC

%IBW

64.1 (4.7)

81.0 (1.6)

98.3 (8.7)

 < 0.001

T1 < T2, T1 < HC, T2 < HC

BMI

13.1 (10.6–14.1)

15.8 (14.2–16.9)

19.8 (16.8–23.6)

 < 0.001

T1 < T2, T1 < HC, T2 < HC

BMI-SDS

 − 4.48 (0.98)

 − 1.82 (0.23)

 − 0.17 (0.66)

 < 0.001

T1 < T2, T1 < HC, T2 < HC

DSRS-C

17.7 (8.4)

12.2 (6.5)

7.8 (5.6)

0.003

T1 > HC

SCAS

48 (8–87)

15.5 (2–73)

17 (3–55)

0.101

 

ChEAT26

38 (7–53)

14 (4–59)

8 (2–30)

 < 0.001

T1 > HC

EDE-Q-J

2.68 (1.60)

1.98 (1.79)

1.06 (0.81)

0.02

T1 > HC

  1. Variables with a normal distribution are presented as mean (standard deviation), while non-normally distributed variables are presented as median (minimum–maximum).
  2. IBW, ideal body weight; BMI, body mass index; SDS, standard deviation score; DSRS-C, Birleson Depression Self-Rating Scale for children; SCAS, Spence Child Anxiety Scale; ChEAT26, Children’s Eating Attitudes Test; EDE-Q-J, Eating Disorder Examination Questionnaire Japanese version; AN, anorexia nervosa; HC, healthy control.
  3. P values indicate results of one-way ANOVA or Kruskal–Wallis test, depending on data distribution.